Publications
More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.
2016
N Engl J Med
Lange C, Günther G, van Leth F, et al.
DOI:
10.1056/NEJMc1613123
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.
2016
Am J Respir Crit Care Med
Lange C, Duarte R, Fréchet-Jachym M, et al.
DOI:
10.1164/rccm.201606-1097LE
The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe - A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey.
2016
Tuberculosis (Edinb)
Kontturi A, Santiago B, Tebruegge M, et al.
DOI:
10.1016/j.tube.2016.08.005
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
2016
N Engl J Med
Günther G, Lange C, Alexandru S, et al.
DOI:
10.1056/NEJMc1603274
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
2016
Int J Tuberc Lung Dis
Domínguez J, Boettger EC, Cirillo D, et al.
DOI:
10.5588/ijtld.15.0221
Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey.
2016
BMC Pregnancy Childbirth
Bothamley GH, Ehlers C, Salonka I, et al.
DOI:
10.1186/s12884-016-1096-4
Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
2016
Tuberculosis (Edinb)
Blauenfeldt T, Wagner D, Aabye M, et al.
DOI:
10.1016/j.tube.2015.04.013
Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
2015
Am J Respir Crit Care Med
Zellweger J-P, Sotgiu G, Block M, et al.
DOI:
10.1164/rccm.201502-0232OC
Numbers needed to treat to prevent tuberculosis.
2015
Eur Respir J
Sester M, van Crevel R, Leth F van, et al.
DOI:
10.1183/13993003.01047-2015
Tuberculosis in young refugees.
2015
Lancet
Ritz N, Brinkmann F, Santiago Garcia B, et al.
DOI:
10.1016/S0140-6736(15)01241-6
Multidrug-resistant tuberculosis in europe, 2010-2011.
2015
Emerging Infect Dis
Günther G, van Leth F, Alexandru S, et al.
DOI:
10.3201/eid2103.141343
Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.
2015
Eur Respir J
Günther G, Gomez GB, Lange C, et al.
DOI:
10.1183/09031936.00124614
Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
2015
Int J Tuberc Lung Dis
Günther G, van Leth F, Altet N, et al.
DOI:
10.5588/ijtld.15.0274
Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
2015
Vaccine
Dierig A, Tebruegge M, Krivec U, et al.
DOI:
10.1016/j.vaccine.2015.06.097
False-negative interferon-γ release assay results in active tuberculosis: a TBNET study.
2015
Eur Respir J
de Visser V, Sotgiu G, Lange C, et al.
DOI:
10.1183/09031936.00120214